NanoVation Therapeutics Inc. (NTx) is a Canadian biotechnology company based in Vancouver, British Columbia, with an additional operation at the Research Complex at Harwell in the United Kingdom.[1] It is focused on gene therapy and the development of "next-generation" lipid nanoparticles (LNP). It is a spin-off company of the NanoMedicines Innovation Network (NMIN).[2]
History
NTx was co-founded by Dominik Witzigmann and Jayesh Kulkarni.[2:1] The company was incorporated in British Columbia on September 3, 2020, and in the United Kingdom on December 7, 2021.[3][4]
On April 20, 2022, NTx announced its expansion into the United Kingdom by launching its so-called "NanoVation GENErator" at the Harwell Science and Innovation Campus in Oxfordshire, England.[2:2]
Innovate BC announced on September 29, 2022, that NTx would receive a $300,000 grant to further the development of mRNA vaccines.[5]
Organization
NTx is a member organization of Life Sciences British Columbia.[6]
Personnel
| Name | Position | Notes |
|---|---|---|
| Marco Ciufolini | Co-founder, Vice President, and Board Director (Canada)[7] | Rice University, Claude Bernard University Lyon 1, University of British Columbia (UBC) |
| Pieter Cullis | Co-founder, Board Chair (Canada), and Board Director (United Kingdom)[8] | Acuitas Therapeutics, UBC Department of Biochemistry & Molecular Biology, adMare BioInnovations, NanoMedicines Innovation Network (NMIN), Royal Society |
| Eric Jan | Co-founder and Board Director (Canada)[7:1] | UBC Department of Biochemistry & Molecular Biology, Stanford University |
| Jayesh Kulkarni | Co-founder and Chief Scientific Officer[2:3][7:2] | NanoMedicines Innovation Network (NMIN), Northern Lipids, BC Cancer Agency, University of British Columbia (UBC), Evonik, NanoMedicines Research Group |
| Dominik Witzigmann | Co-founder and CEO[2:4][7:3] | NanoMedicines Innovation Network (NMIN), UCL School of Pharmacy, German Cancer Research Center, University of Basel Department of Pharmaceutical Sciences, Schwank Lab, University of British Columbia (UBC),[9] Controlled Release Society (CRS), Biozentrum, Swiss Nanoscience Institute (NSI)[10], European Society for Nanomedicine, Swiss Academy of Pharmaceutical Sciences, German Pharmaceutical Society (DPhG) |
| Marion Athané | Marketing & Events Manager[11] | NanoMedicines Innovation Network (NMIN)[12] |
| N. D. Prasad Atmuri | Associate Principal Scientist, Chemistry[7:4] | University College London (UCL), University of Oxford, Hetero, Syngene, University of Montreal, University of British Columbia (UBC), StrongerBC, Mitacs[13] |
| Martin Attwood | Senior Scientist, Biology[7:5] | University College London (UCL), University of Oxford |
| Hanna Barriga | Consultant, Biophysics[7:6] | Imperial College London (ICL), Karolinska Institute, Pfizer, Swedish Neutron Scattering Society (SNSS), KTH Royal Institute of Technology, New York Academy of Sciences[14] |
| Marshall Beck | Communications and IT Consultant[7:7] | NanoMedicines Innovation Network (NMIN), Centre for Research on Latin America and the Caribbean (CERLAC), CHILD Cohort Study, Centre for Refugee Studies (CRS), North American Congress on Latin America (NACLA)[15] |
| Mayara Brandao | Senior Manager, People and Culture[7:8] | VanHack, Community Living Society (CLS), Footprints Recruiting, Recife Center for Advanced Studies and Systems (CESAR), Grupo Contax[16] |
| David Broemeling | Vice President of Operations[7:9] | Boreal Genomics, Creative Destruction Lab (CDL), University of British Columbia (UBC), Natera[17] |
| Frederick Campbell | Scientific Director, UK[18] | University College London (UCL), Leiden University[19] |
| Tony Cheung | Vice President of Finance[7:10] | TIR Systems, Pacific Cellular, Lignol Energy Corporation, Evonik, Portable Electric, Transferra Nanosciences, Canadian Fishing Company (Canfisco), Scouts Canada[20] |
| Christine DeMatteis | Lab Manager[7:11] | Zymeworks, CARO Analytical Services[21] |
| Arpan Desai | Managing Director, UK (March 2022-January 2024)[2:5][22] | Visiongain, University of Melbourne, University of Nottingham, AstraZeneca, CamGene Therapeutics |
| Allison Enjetti | Senior Project Manager[7:12] | AbCellera, U.S. President's Malaria Initiative, British Columbia Centre for Excellence in HIV/AIDS[23] |
| Don Enns | Chief Business Officer[7:13] | Molecular You, Evonik, Life Sciences British Columbia, Genome British Columbia[24] |
| Julia Ayano Fernando | Scientist, Biology[7:14] | HKU-Pasteur Research Pole, Swansea University |
| Bruno Fonseca | RNA Director[7:15] | University of British Columbia (UBC), McGill University, AstraZeneca, Children's Hospital of Eastern Ontario (CHEO), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), PrimerGen[25] |
| Georgina Girt | Senior Scientist, Formulation (UK)[7:16] | University of Oxford, Rosalind Franklin Institute (RFI), University of Leicester[26] |
| Rupsa Gupta | Senior Associate Scientist, Formulation[7:17] | Precision NanoSystems, NanoMat, Mitacs, Lower Mainland Bengali Cultural Society[27] |
| Graham Hayes | Senior Scientist, Formulation[7:18] | Infineum, University of Warwick[28] |
| Kate Hollinshead | Senior Scientist, Translational Science[29] | MedImmune, AstraZeneca, NYU Langone Health |
| Joshua Jeyakumar | Patent Associate[7:19] | Intellectual Property Institute of Canada (IPIC), MaxVal Group, Effectual Services, Stellarix Consultancy Services[30] |
| Japneet Kaur | Preclinical Research Technician[7:20] | - |
| Daniel Kurek | Senior Scientist III, Formulation, Team Lead[7:21] | University of Utah, BC Research, University of British Columbia (UBC), Evonik[31] |
| Wendy Lamson | Chief Intellectual Property Officer[7:22] | Intellectual Property Institute of Canada (IPIC), University of Ottawa, Lamson IP, Perley-Robertson, Hill & McDougall, Kirby Eades Gale Baker, Iogen, Celator Pharmaceuticals[32] |
| Rafaela Marodin | Senior Research Associate, Formulation[7:23] | Simon Fraser University (SFU), Renaissance BioScience, University of British Columbia (UBC), adMare BioInnovations[33] |
| Michelle Martin | Human Resources Consultant[7:24] | Forbes Medi-Tech, thriveHR, Aquinox Pharmaceuticals[34] |
| Nigel McKenzie | Senior Manager, Operations[7:25] | Natera, Celtic Reforestation, Quest University, BC Wildfire Service, Tübify Foods, SPUD, Smash + Tess, WERD Magazine, Momenta[35] |
| Lívia Palmerston Mendes | Senior Scientist I, Formulation[7:26] | Federal University of Goiás, Cifarma Científica Farmacêutica, Antimicrobial Discovery Center (ADC), Northeastern University, CureVac, Controlled Release Society, Abroaders[36] |
| Ardalan Nabi | Scientist I, Chemistry[7:27] | UBC Department of Chemistry, Soran University, University of Auckland[37] |
| Ariane Nissenbaum | Senior Associate Scientist, RNA[7:28] | Sunnybrook Health Sciences Centre, College of San Mateo (CSM), Atlantis, San Francisco State University, University of California, San Francisco (UCSF), Genentech, UCSF Benioff Children's Hospital at Mission Bay[38] |
| Maryam Osooly | Preclinical Research Technician[7:29] | BC Cancer Research Centre (BCCRC) |
| Grishma Pawar | Scientist II, Preclinical[7:30] | Krembil Brain Institute (KBI), Maneesh Pharmaceuticals, Vivekanand Education Society College of Pharmacy, Sanofi, Northeastern University, Kalia Labs, University Health Network Postdoc Association (UHNPA), Indian Pharmaceutical Association (IPA)[39] |
| Nicola Pett | Preclinical Research Associate[7:31] | University of Calgary, University of Queensland |
| Atul Rangadurai | Scientist I, RNA[7:32] | University of Toronto, SickKids, Indian Institute of Science (IISc)[40] |
| Eleonore Rayner | Project Manager[7:33] | University of British Columbia (UBC), Hammersmith Medicines Research (HMR), Kastrup Lab, Michael Smith Laboratories[41] |
| Fariba Saadati | Senior Scientist III, Chemistry[7:34] | University of British Columbia (UBC), Institute for Advanced Studies in Basic Sciences (IASBS) |
| Jessica Silva | Scientist, Preclinical Immunology[7:35] | University of Tennessee at Martin, UBC Department of Microbiology and Immunology, Ronald McDonald House Charities, Phi Eta Sigma, Phi Kappa Phi[42] |
| Molly Stevens | Scientific Advisor (Canada) and Board Member (UK)[43] | Imperial College London (ICL), Karolinska Institute, Royal Society, Royal Academy of Engineering, National Academy of Engineering (NAE) |
| Anthony Tam | Scientist II, Preclinical Research[7:36] | Vancouver Biotech Limited (VBL), British Columbia Institute of Technology (BCIT), University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Mitacs[44] |
| Huy Tran | Scientist II, Chemistry[7:37] | University of Ottawa, Theravance Biopharma, Cytokinetics, Chemistry and Biomolecular Graduate Student Association (CBGSA), Queensway Carleton Hospital[45] |
| Xinying Wang | RNA Scientist[7:38] | - |
| John Williams | Company Secretary (UK)[7:39] | Institute of Chartered Accountants in England and Wales (ICAEW) |
| Kathy Wong | Research Associate, RNA[7:40] | British Columbia Centre for Disease Control (BCCDC) |
| Caroline Ye | Senior Scientist I, Formulation[7:41] | Precision NanoSystems, Imperial College London (ICL), Kastrup Lab, Cat Therapy & Rescue Society[46] |
Patents
- WO 2024/065043 A1: Amino acid-containing ionizable lipids for the delivery of therapeutics agents
- Inventors: Prasad Atmuri, Fariba Saadati, Marco Ciufolini
- Agent: Wendy Lamson
External links
NanoVation Therapeutics UK. Research Complex at Harwell. Retrieved September 11, 2024, from https://ghostarchive.org/archive/BoY51 ↩︎
NMIN spin-off company NanoVation Therapeutics is expanding into UK. (2022, April 20). Nanomedicines Innovation Network. https://web.archive.org/web/20220525201917/https://www.nanomedicines.ca/2022/04/20/nanovation-expands-into-uk/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
OrgBook BC. (2023, October 15). NanoVation Therapeutics Inc. OpenCorporates. https://opencorporates.com/companies/ca_bc/BC1264242 ↩︎
UK Companies House. (2024, July 1). NanoVation Therapeutics UK Ltd. OpenCorporates. https://opencorporates.com/companies/gb/13786991 ↩︎
Innovate BC Awards $2.3M to B.C. R&D Projects. (2022, September 30). Innovate BC. https://web.archive.org/web/20220930020529/https://www.innovatebc.ca/en/news/innovate-bc-awards-2.3m-to-b.c.-rd-projects ↩︎
NanoVation Therapeutics. Life Sciences British Columbia. Retrieved February 6, 2024, from https://web.archive.org/web/20240206065115/https://lifesciencesbc.ca/member/NanoVationTherapeutics/ ↩︎
Team. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907003826/https://nanovationtx.com/team/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Pieter Cullis. NanoVation Therapeutics. Retrieved September 6, 2024, from http://archive.today/2024.09.06-235013/https://nanovationtx.com/1cullis/ ↩︎
Experience | Dominik Witzigmann. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/dominikwitzigmann/details/experience/ ↩︎
Volunteering | Dominik Witzigmann. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/dominikwitzigmann/details/volunteering-experiences/ ↩︎
Marion Athané. NanoVation Therapeutics. Retrieved September 6, 2024, from https://web.archive.org/web/20240906232247/https://nanovationtx.com/athane/ ↩︎
Experience | Marion Athané. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/marion-athané-094a6560/details/experience/ ↩︎
N. D. Prasad Atmuri, Ph.D. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/n-d-prasad-atmuri-ph-d-b6048957/ ↩︎
Hanna Barriga. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/hanna-barriga-7a168442/ ↩︎
Experience | Marshall Beck. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/marshall-beck-1308a040/details/experience/ ↩︎
Experience | Mayara Brandao. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/mayarabr/details/experience/ ↩︎
David Broemeling. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/david-broemeling/ ↩︎
Frederick Campbell. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907001606/https://nanovationtx.com/campbellf/ ↩︎
Fred Campbell. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/fred-campbell-916591228/ ↩︎
Tony Cheung. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/tony-cheung-7725b647/ ↩︎
Christine DeMatteis. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/christine-dematteis-32630b243/ ↩︎
Experience | Arpan Desai. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/arpandesaiuk/details/experience/ ↩︎
Experience | Allison Enjetti, MSc. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/allison-enjetti-msc-22397424/details/experience/ ↩︎
Experience | Don Enns. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/don-enns-1b222a30/details/experience/ ↩︎
Experience | Bruno Fonseca, PhD. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/bruno-fonseca-phd-a7279410/details/experience/ ↩︎
Georgia Girt. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/georginagirt/ ↩︎
Rupsa Gupta. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/rupsa-gupta-8a70b9129/ ↩︎
Graham Hayes. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/graham-hayes-097122136/ ↩︎
Kate Hollinshead. NanoVation Therapeutics. Retrieved September 6, 2024, from https://web.archive.org/web/20240906235900/https://nanovationtx.com/hollinshead/ ↩︎
Joshua I.R. Jeyakumar. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/joshuaimmanuelj/ ↩︎
Daniel Kurek. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/daniel-kurek-a0910789/ ↩︎
Wendy Lamson. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/wendy-lamson-61a673a/ ↩︎
Rafaela Marodin. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/rafaela-marodin/ ↩︎
Michelle Martin, CPHR, SHRM-SCP. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/michelle-martin-cphr-shrm-scp-149bb07/ ↩︎
Experience | Nigel McKenzie. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/nigelmckenzie/details/experience/ ↩︎
Lívia Palmerston Mendes. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/liviapmendes/ ↩︎
Experience | Ardalan Nabi. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/ardalan-nabi-8817401a2/details/experience/ ↩︎
Experience | Ariane Miriam Nissenbaum. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/arianemn/details/experience/ ↩︎
Grishma Pawar, Ph.D. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/grishma-pawar-ph-d-38b6ab18/ ↩︎
Atul Kaushik Rangadurai, PhD. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/atul-rangadurai/ ↩︎
Eleonore Rayner. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/eleonorerayner/ ↩︎
Jessica Silva. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/jessica-afd-silva/ ↩︎
Molly Stevens. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907002042/https://nanovationtx.com/stevens/ ↩︎
Anthony T. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/anthony-t-ab200a20/ ↩︎
Huy Tran, Ph.D. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/huytranchem/ ↩︎
Caroline Ye. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/caroline-ye96/ ↩︎
